Compare ARK Genomic Revolution ETF (ARKG) vs TORM plc (TRMD) Price & Performance
Price performance
Price movement over the last 24 hours
Key statistics
Key statistics
ARK Genomic Revolution ETF vs TORM plc — how do they compare? ARK Genomic Revolution ETF trades at $40.95, while TORM plc trades at $29.65 (market cap $2.94B). The key difference: TORM plc pays a 9.5% dividend while ARK Genomic Revolution ETF pays none, and ARK Genomic Revolution ETF is trading nearer its 52-week high, TORM plc nearer its low. Which is the better fit depends on your goals.
| ARKG | TRMD | |
|---|---|---|
Sector | Sector/Thematic | Technology |
52-Week High | $43.57 | $34.87 |
52-Week Low | $23.09 | $17.46 |
Market Cap | — | $2.94B |
Enterprise Value | — | $3.82B |
Dividend Yield | — | 9.5% |
Aura AI Summary
Signals from Pluang's Aura AI — not financial advice
Aura AI Summary
Signals from Pluang's Aura AI — not financial advice
ARKG trades at $41.32, down 3.91% today, with a bullish technical signal driven by moving averages. Recent news highlights biotech ETF strength in June 2026, fueled by strong earnings, M&A activity, and AI-driven drug discovery optimism. Key support lies at $40, with resistance at $44.
The outlook remains positive given sector tailwinds, but risks include regulatory hurdles and market volatility. Investor sentiment is buoyed by industry growth catalysts, though selective investment approaches are noted by analysts.
TRMD trades at $29.48, up 5.06% today, with technical indicators showing a neutral bias and support near $28. The stock exhibits strong profitability with a 24.41% net margin and attractive valuation at a P/E of 8.65. Recent Q1 2026 earnings missed estimates but full-year guidance was raised, reflecting robust tanker market conditions. A $0.70 dividend for H1 2026 underscores shareholder returns.
Outlook remains positive given firm freight rates and strategic execution, though volatility from geopolitical factors and earnings misses pose risks. Analyst consensus is unanimously bullish, supporting upside potential if operational targets are met.
Returns comparison
Trailing returns across standard periods
Returns comparison
Trailing returns across standard periods
About ARK Genomic Revolution ETF
ARKG is an actively managed ETF that invests in the genomic revolution. It focuses on companies leading in gene editing, CRISPR technology, therapeutics, and molecular diagnostics, including firms like CRISPR Therapeutics and Tempus AI.
Read more on ARKG →About TORM plc
TORM plc is one of the world's largest owners and operators of product tankers, specializing in the transportation of refined oil products like gasoline, jet fuel, and diesel. Operating under its integrated 'One TORM' model, the company maintains a modern, wholly-owned fleet of nearly 90 vessels. It is widely recognized by investors for its aggressive variable dividend policy, which returns a significant portion of its cash flow directly to shareholders during periods of high freight rates.
Read more on TRMD →
